[ad_1]
Three new cases of atypical thrombosis associated with the AstraZeneca coronavirus vaccine were reported in France between March 19 and 25, AFP reported, citing health authorities. Two cases ended in death.
Since the start of the vaccination campaign in France, there have been 12 cases, 4 of which ended in death, of these rare thromboses, announced the French Medicines Agency.
These are atypical thromboses of the great veins, largely cerebral, but also of the digestive system, which may be associated with thrombocytopenia (platelet deficiency) or clotting problems.
However, the French Medicines Agency recalls that the European Medicines Agency has confirmed that the benefits of the vaccine outweigh the risks.
Cases in France occurred on average nine days after vaccination, mainly in women without previously reported illnesses. Nine people were under 55 and three were over 55.
The French Medicines Agency recommends that people who have been vaccinated with this product consult a doctor immediately in case of symptoms lasting more than three days, such as shortness of breath, chest pain, leg swelling, stomach pain , severe headache, blurred vision. . or bruising away from the injection site.
France
[ad_2]
